1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Navigating discrepancies : The assessment of residual lymphovascular invasion in breast carcinoma after neoadjuvant treatment
- Contribution to journal › Article
-
Mark
A bottom-up initiated digital external quality assessment scheme for the state-of-the-art pathology in Sweden : reduced variability between pathology departments
(2025) In Virchows Archiv
- Contribution to journal › Article
-
Mark
Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer : a Swedish population-based cohort study
- Contribution to journal › Article
